Menu
Search
|

Menu

Close
X

Bayer AG BAYGN.DE (Xetra)

97.92 EUR
-0.52 (-0.53%)
As of Feb 23
chart
Previous Close 98.44
Open 98.71
Volume 2,015,889
3m Avg Volume 2,442,642
Today’s High 98.79
Today’s Low 97.58
52 Week High 123.90
52 Week Low 94.72
Shares Outstanding (mil) 826.95
Market Capitalization (mil) 80,974.73
Forward P/E 23.13
Dividend (Yield %) 2.70 ( 2.76 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.07 Mean rating from 28 analysts

KEY STATS

Revenue (mm, EUR)
FY17
33,462
FY16
43,765
FY15
46,085
EPS (EUR)
FY17
4.400
FY16
4.950
FY15
4.867
*Note: Units in Millions of Euro
**Note: Units in Euro

KEY RATIOS

Price to Earnings (TTM)
vs sector
23.13
33.62
Price to Sales (TTM)
vs sector
2.12
8.35
Price to Book (MRQ)
vs sector
2.18
5.22
Price to Cash Flow (TTM)
vs sector
12.53
25.88
Total Debt to Equity (MRQ)
vs sector
43.33
15.84
LT Debt to Equity (MRQ)
vs sector
33.81
12.39
Return on Investment (TTM)
vs sector
6.21
13.63
Return on Equity (TTM)
vs sector
12.16
15.39

EXECUTIVE LEADERSHIP

Werner Wenning
Chairman of the Supervisory Board, Since 2012
Salary: €360,000.00
Bonus: --
Werner Baumann
Chairman of the Management Board, Chief Executive Officer, Since 2016
Salary: €1,285,000.00
Bonus: €2,329,000.00
Oliver Zuehlke
Vice Chairman of the Supervisory Board, Employee Representative, Since 2015
Salary: €240,000.00
Bonus: --
Johannes Dietsch
Chief Financial Officer, Member of the Management Board, Since 2014
Salary: €750,000.00
Bonus: €978,000.00
Hartmut Klusik
Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director, Since 2016
Salary: €750,000.00
Bonus: €1,053,000.00

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Kaiser-Wilhelm-Allee 1
LEVERKUSEN     51373

Phone: +49214.301

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Pharmaceuticals division also comprises the radiology business. The Consumer Health segment is engaged in the development, production and marketing of mainly nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products. The Covestro segment is engaged in the development, production and marketing of raw materials for polyurethanes, polycarbonate granules and sheets and raw materials for coatings, adhesives.

SPONSORED STORIES